Jia Jie Biomedical Co., Ltd. (TPEX:4109)
Taiwan · Delayed Price · Currency is TWD 11.30
-0.10 (-0.88%)
Aug 19, 2026, 10:34 AM CST
Jia Jie Biomedical Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 514.65 | 485.4 | 537.07 | 332.76 | 317.72 | 242.48 |
Revenue Growth | 10.74% | -9.62% | 61.40% | 4.73% | 31.03% | -10.29% |
Gross Profit Gross Profit Growth | 138.7 | 150.34 | 173.35 | 117.64 | 116.51 | 83.77 |
Operating Income Operating Income Growth | -11.51 | 0.71 | 33.17 | -66.2 | -13.68 | -0.93 |
Net Income Net Income Growth | 3.09 | 50.26 | 211.37 | 144.15 | -5.47 | 5.34 |
Earnings Per Share EPS Growth | 0.03 | 0.43 | 2.15 | 1.62 | -0.06 | 0.06 |
EPS Growth | - | -80.00% | 32.72% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Insurance Brokerage Business Insurance Brokerage Business Growth | 65.49 | 65.9 | 59.64 | 62.88 | 64.7 | - |
Ready-To-Eat Food Manufacturing Ready-To-Eat Food Manufacturing Growth | 209.95 | 197.28 | 166.58 | - | - | - |
Nutrition and Health Products Nutrition and Health Products Growth | 220.04 | 229.32 | 305.87 | 263.68 | 243.11 | - |
Other Other Growth | 7.4 | 6.85 | 7.44 | 9.98 | 9.9 | - |
Adjustments and Write-Offs Adjustments and Write-Offs Growth | -15.21 | -13.94 | -2.46 | -3.78 | - | -1.41 |
Total Total Growth | 487.66 | 485.4 | 537.07 | 332.76 | 317.72 | 242.48 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 500.33 | 481.56 | 263.05 | 384.17 | 253.75 | 286.31 |
Total Debt Total Debt Growth | 92.26 | 56.27 | 8.48 | 243.9 | 8.8 | 6.61 |
Net Cash (Debt) Net Cash Growth | 408.07 | 425.29 | 254.57 | 140.26 | 244.95 | 279.69 |
Net Cash Growth | -24.11% | 67.06% | 81.49% | -42.74% | -12.42% | -17.73% |
Net Cash Per Share Net Cash Per Share Growth | 3.46 | 3.65 | 2.59 | 1.57 | 2.75 | 3.14 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 13.04 | 21.34 | 44.35 | -4.49 | -8.78 | 4.37 |
Capital Expenditures CapEx Growth | -65.39 | -85.5 | -19.63 | -8.61 | -17.86 | -1.52 |
Free Cash Flow Free Cash Flow Growth | -52.35 | -64.15 | 24.72 | -13.1 | -26.64 | 2.85 |
Free Cash Flow Growth | - | - | - | - | - | -88.79% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 26.95% | 30.97% | 32.28% | 35.35% | 36.67% | 34.55% |
Operating Margin | -2.24% | 0.15% | 6.18% | -19.89% | -4.31% | -0.38% |
Pretax Margin | 0.53% | 12.33% | 41.98% | 44.04% | -1.47% | 2.18% |
Profit Margin | 0.60% | 10.35% | 39.36% | 43.32% | -1.72% | 2.20% |
FCF Margin | -10.17% | -13.22% | 4.60% | -3.94% | -8.38% | 1.18% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.200 | 0.200 | 0.500 | 0.500 |
Dividend Per Share Growth | -60.00% | -60.00% | 0% | - |
Dividend Yield | 1.80% | 1.29% | 2.37% | 3.13% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 437.63 | 36.62 | 10.42 | 10.61 | - | 223.17 |
P/FCF Ratio | - | - | 89.07 | - | - | 417.57 |
PS Ratio | 2.63 | 3.79 | 4.10 | 4.60 | 4.12 | 4.92 |